S Michelacci

542 total citations
22 papers, 434 citations indexed

About

S Michelacci is a scholar working on Psychiatry and Mental health, Neurology and Physiology. According to data from OpenAlex, S Michelacci has authored 22 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 4 papers in Neurology and 4 papers in Physiology. Recurrent topics in S Michelacci's work include Migraine and Headache Studies (13 papers), Pain Mechanisms and Treatments (3 papers) and Neuropeptides and Animal Physiology (3 papers). S Michelacci is often cited by papers focused on Migraine and Headache Studies (13 papers), Pain Mechanisms and Treatments (3 papers) and Neuropeptides and Animal Physiology (3 papers). S Michelacci collaborates with scholars based in Italy and Netherlands. S Michelacci's co-authors include M Fanciullacci, Pierangelo Geppetti, Michela Figini, Massimo Alessandri, F Sicuteri, G Franchi, B. Anselmi, J Lecomte, Maria Grazia Spillantini and Paolo Conti and has published in prestigious journals such as Pain, Cellular and Molecular Life Sciences and European Journal of Pharmacology.

In The Last Decade

S Michelacci

21 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Michelacci Italy 9 302 187 170 93 54 22 434
Tokio Shimomura Japan 13 220 0.7× 97 0.5× 141 0.8× 46 0.5× 62 1.1× 26 421
Umberto Pietrini Italy 11 160 0.5× 130 0.7× 132 0.8× 42 0.5× 39 0.7× 27 313
J. Németh Hungary 8 191 0.6× 125 0.7× 217 1.3× 168 1.8× 100 1.9× 9 510
Mingyan Hou Sweden 9 214 0.7× 102 0.5× 182 1.1× 100 1.1× 128 2.4× 10 544
P. R. Saxena Netherlands 11 87 0.3× 58 0.3× 127 0.7× 73 0.8× 82 1.5× 16 338
K. Roger Aoki United States 4 180 0.6× 122 0.7× 190 1.1× 58 0.6× 24 0.4× 6 385
AMJM van den Maagdenberg Netherlands 10 252 0.8× 80 0.4× 74 0.4× 45 0.5× 87 1.6× 11 340
V. Pizza Italy 12 181 0.6× 82 0.4× 119 0.7× 35 0.4× 66 1.2× 30 421
E Chabi United States 10 83 0.3× 37 0.2× 88 0.5× 115 1.2× 97 1.8× 14 375
Tobias Leniger Germany 12 264 0.9× 60 0.3× 38 0.2× 174 1.9× 181 3.4× 20 468

Countries citing papers authored by S Michelacci

Since Specialization
Citations

This map shows the geographic impact of S Michelacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Michelacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Michelacci more than expected).

Fields of papers citing papers by S Michelacci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Michelacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Michelacci. The network helps show where S Michelacci may publish in the future.

Co-authorship network of co-authors of S Michelacci

This figure shows the co-authorship network connecting the top 25 collaborators of S Michelacci. A scholar is included among the top collaborators of S Michelacci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Michelacci. S Michelacci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fanciullacci, M, Massimo Alessandri, Michela Figini, Pierangelo Geppetti, & S Michelacci. (1995). Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain. 60(2). 119–123. 233 indexed citations
2.
Fanciullacci, M, Massimo Alessandri, Maria Nicolodi, S Michelacci, & F Sicuteri. (1993). Possible long-lasting inhibition of converting enzyme by enalapril in human cerebrospinal fluid. Clinical Science. 84(3). 313–317. 3 indexed citations
3.
Michelacci, S, et al.. (1986). Analgesizing effect of a methyl donor (S-adenosylmethionine) in migraine: an open clinical trial.. PubMed. 6(1). 15–7. 8 indexed citations
4.
Spillantini, Maria Grazia, et al.. (1986). In vivo ‘enkephalinase’ inhibition by acetorphan in human plasma and CSF. European Journal of Pharmacology. 125(1). 147–150. 38 indexed citations
5.
Michelacci, S, et al.. (1983). Lisuride as a migraine prophylactic in children: an open clinical trial.. PubMed. 3(2). 137–41. 12 indexed citations
6.
Fanciullacci, M, et al.. (1982). A putative 5-HT central feedback in migraine and cluster headache attacks.. PubMed. 33. 265–74. 12 indexed citations
7.
Fanciullacci, M, et al.. (1980). Hyperresponsiveness of Migraine Patients to the Hypotensive Action of Bromocriptine. Headache The Journal of Head and Face Pain. 20(2). 99–102. 22 indexed citations
8.
Sicuteri, F, et al.. (1978). Morphine-like factors in CSF of headache patients.. PubMed. 18. 363–6. 13 indexed citations
9.
Sicuteri, F, M Fanciullacci, & S Michelacci. (1978). Decentralization Supersensitivity in Headache and Central Panalgesia. 19–33. 8 indexed citations
10.
Fanciullacci, M, G Franchi, & S Michelacci. (1972). Indomethacin as a Drug Capable of Provoking or Breaking off Headache1. PubMed. 3. 335–342. 4 indexed citations
11.
Franchi, G, B. Anselmi, & S Michelacci. (1972). Change in Serotonin and Catecholamines Vascular Reactivity During Migraine Attack1. PubMed. 3. 304–309. 2 indexed citations
12.
Sicuteri, F, G Franchi, M Fanciullacci, S Michelacci, & P. L. Del Bianco. (1971). Clinical Pharmacology of Vasopeptide and Amine Motoreceptors of Intracranial Circulation. European Neurology. 6(1-6). 158–161. 3 indexed citations
13.
Sidell, Neil, et al.. (1969). Local ischemia as a kininogen depressant: Effect of cortisone, taurine and kallikrein inhibitor. Pharmacological Research Communications. 1(2). 137–138. 5 indexed citations
14.
Sicuteri, F, S Michelacci, & B. Anselmi. (1965). Termination of migraine headache by a new anti‐inflammatory vasoconstrictor agent. Clinical Pharmacology & Therapeutics. 6(3). 336–344. 16 indexed citations
15.
Sicuteri, F, et al.. (1964). FIBRINOLYTIC PROPERTIES OF THE VASODILATING ENDECAPEPTIDE ELEDOISIN IN MAN.. PubMed. 151. 38–40. 1 indexed citations
16.
Sicuteri, F, M Fanciullacci, G Franchi, & S Michelacci. (1963). The endecapeptide eledoisin as powerful vasodilating and hypotensive agent in man. Cellular and Molecular Life Sciences. 19(1). 44–47. 27 indexed citations
17.
Sicuteri, F, et al.. (1963). Coagulation Changes During Migraine. Angiology. 14(12). 580–583. 4 indexed citations
18.
Sicuteri, F, S Michelacci, & G Franchi. (1963). The Activation of Mast Cells by the Histamine Liberator 48/80 in Man. International Archives of Allergy and Immunology. 22(6). 408–415. 8 indexed citations
19.
Michelacci, S & G Franchi. (1962). [Treatment of vascular headaches with nialamide, a monoamine oxidase inhibitor].. PubMed. 53. 1521–3. 2 indexed citations
20.
Sicuteri, F, et al.. (1959). Antagonism Between an Antiserotonin – the Butanolamide of 1-Methyl-Lysergic Acid – and the Effects of a Histamine-Liberating Substance 48/80 B. W. in Man. International Archives of Allergy and Immunology. 15(4-5). 291–299. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026